Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy
Abstract. Background:. Diabetic nephropathy (DN) is a common microvascular complication of diabetes, which poses a serious threat to the health and life of patients. There is evidence that both α lipoic acid and olmesartan medoxomil have positive effects in the treatment of DN, but whether the 2 hav...
Main Authors: | Shengfu Jiao, MB, Yuxia Dong, MB, Xiang Chang, MB, Yanan Wu, MB, Haifeng Li, MB |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-04-01
|
Series: | Medicine |
Online Access: | http://journals.lww.com/10.1097/MD.0000000000029080 |
Similar Items
-
Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
by: Mark Greathouse
Published: (2006-12-01) -
EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01) -
Olmesartan medoxomil: current status of its use in monotherapy
by: Hans R Brunner
Published: (2006-12-01) -
Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01) -
Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)